Related Experiment Video
Updated: Jun 1, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Human lysozyme has fungicidal activity against nasal fungi
Charmaine M Woods1, David N Hooper, Eng H Ooi
1Flinders ENT, Department of Surgery, Flinders University and Flinders Medical Centre, Adelaide, Australia.
Background:
The cationic antimicrobial peptide lysozyme is the most prevalent innate immune protein in nasal secretions but there is a paucity of research regarding its role in paranasal sinus disease. Lysozyme is generally regarded as an antibacterial agent; however, some data suggest activity toward yeast. This study was designed to determine if lysozyme displays fungicidal activity toward fungi commonly identified in patients with chronic rhinosinusitis (CRS) or fungal sinusitis.
Methods:
Using a colony-forming unit assay the fungicidal activity of lysozyme (0, 0.5, 5, and 50 micromolar; 0- to 7-hour treatment) was tested against strains of Aspergillus fumigatus, the yeast Candida albicans, and other fungi commonly identified in mucin of patients with CRS. Fungi cultured directly from the mucin of two CRS patients were also tested to determine if they were resistant to the fungicidal activity of lysozyme.
Results:
The fungicidal effect of lysozyme was both concentration and time dependent. After 7-hour treatment lysozyme (5 micromolar) had >80% fungicidal activity against A. fumigatus, Penicillium sp., Acremonium sp., C. albicans, and Candida parapsilosis. The fungicidal activity of lysozyme toward Alternaria alternata could not be determined. Lysozyme was also fungicidal toward the clinical isolates A. fumigatus and Aspergillus terreus cultured from the mucin of CRS patients.
Conclusion:
Lysozyme displays fungicidal activity toward many fungi commonly identified in patients with CRS, as well as clinical fungi isolates cultured from the mucin of CRS patients. Additional studies are required to determine the regulation of lysozyme in CRS.
Insights
Lysozyme, an innate immune protein, effectively kills fungi commonly found in chronic rhinosinusitis (CRS). This study demonstrates lysozyme
Area of Science:
- Immunology
- Microbiology
- Otolaryngology
Background:
- Lysozyme is a key innate immune protein in nasal secretions.
- Its role in paranasal sinus disease and antifungal activity is under-researched.
- This study investigates lysozyme's fungicidal effects against CRS-associated fungi.
Purpose of the Study:
- To determine the fungicidal activity of lysozyme against common fungal pathogens in chronic rhinosinusitis (CRS).
- To assess lysozyme's efficacy against clinical fungal isolates from CRS patients.
Main Methods:
- Colony-forming unit assays were used to test lysozyme's fungicidal activity.
- Concentrations of 0-50 micromolar and treatment durations of 0-7 hours were evaluated.
- Tested fungi included Aspergillus fumigatus, Candida albicans, and clinical CRS isolates.
Main Results:
- Lysozyme demonstrated concentration- and time-dependent fungicidal activity.
- Over 80% fungicidal activity was observed against multiple fungal species, including A. fumigatus and C. albicans, after 7-hour treatment with 5 micromolar lysozyme.
- Lysozyme was also effective against clinical isolates of A. fumigatus and Aspergillus terreus.
Conclusions:
- Lysozyme exhibits significant fungicidal activity against fungi prevalent in CRS.
- The findings support a potential therapeutic role for lysozyme in managing fungal sinusitis.
- Further research is needed to understand lysozyme regulation in CRS.
Related Concept Videos
Antifungal Agents
Fungal Group Zygomycota
Lysosomal Hydrolases
Overview of Fungi
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Chemical Agents for Microbial Control
